MedTrace Logo

The Hydration to Optimize Metabolism (H2O Metabolism) Pilot Study

NCT03574688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2018-07-03

No results posted yet for this study

Summary

This study evaluates increased hydration (1.5 L of water daily during 6 weeks) on top of habitual water intake in the lowering of the vasopressin marker copeptin and in the lowering of plasma glucose concentration in adults with signs of low water intake at recruitment (elevated levels of copeptin, high urine osmolality, low urine volume).

Conditions

  • Low Water Intake
  • High Vasopressin

Interventions

DIETARY_SUPPLEMENT

Water

Increased daily water intake with 1.5 Liters of water per day on top of habitual water intake.

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Danone Global Research & Innovation Center

    collaborator INDUSTRY

  • Region Skane

    lead OTHER

Principal Investigators

  • Olle Melander, M.D., Prof · Lund University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-02
Primary Completion
2017-07-25
Completion
2017-07-25

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574688 on ClinicalTrials.gov